ERMA logo

Enorama Pharma AB (publ) Stock Price

OM:ERMA Community·SEK 208.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ERMA Share Price Performance

SEK 2.80
-1.06 (-27.46%)
SEK 2.80
-1.06 (-27.46%)
Price SEK 2.80

ERMA Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with mediocre balance sheet.

6 Risks
0 Rewards

Enorama Pharma AB (publ) Key Details

SEK 11.3m

Revenue

SEK 18.7m

Cost of Revenue

-SEK 7.4m

Gross Profit

SEK 62.9m

Other Expenses

-SEK 70.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.94
-65.66%
-622.31%
0%
View Full Analysis

About ERMA

Founded
2006
Employees
5
CEO
Daniel Schroder
WebsiteView website
www.enorama.se

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company was incorporated in 2006 and is based in Malmö, Sweden.

Recent ERMA News & Updates

Recent updates

No updates